" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "
Clinical trial NCT06983756 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06983756
- Sponsor
- Fayoum University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-01
- Primary completion
- 2025-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.